Cargando…

Crystal structure of nafamostat dimesylate

Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anti­coagul...

Descripción completa

Detalles Bibliográficos
Autor principal: Fujii, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491525/
https://www.ncbi.nlm.nih.gov/pubmed/34667626
http://dx.doi.org/10.1107/S2056989021009245
_version_ 1784578749462740992
author Fujii, Isao
author_facet Fujii, Isao
author_sort Fujii, Isao
collection PubMed
description Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anti­coagulant agent during hemodialysis and for treatment of severe acute pancreatitis (SAP). Since nafamostat contains flexible moieties, it is necessary to determine the conformation to understand the structure–activity relationships. The divalent cation has a screw-like motif. The guanidinium group is approximately perpendicular to the naphthyl ring system, subtending a dihedral angle of 84.30 (14)°. In the crystal, the nafamostat mol­ecules form columnar structures surrounded by a hydro­philic region.
format Online
Article
Text
id pubmed-8491525
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-84915252021-10-18 Crystal structure of nafamostat dimesylate Fujii, Isao Acta Crystallogr E Crystallogr Commun Research Communications Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anti­coagulant agent during hemodialysis and for treatment of severe acute pancreatitis (SAP). Since nafamostat contains flexible moieties, it is necessary to determine the conformation to understand the structure–activity relationships. The divalent cation has a screw-like motif. The guanidinium group is approximately perpendicular to the naphthyl ring system, subtending a dihedral angle of 84.30 (14)°. In the crystal, the nafamostat mol­ecules form columnar structures surrounded by a hydro­philic region. International Union of Crystallography 2021-09-10 /pmc/articles/PMC8491525/ /pubmed/34667626 http://dx.doi.org/10.1107/S2056989021009245 Text en © Isao Fujii 2021 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Research Communications
Fujii, Isao
Crystal structure of nafamostat dimesylate
title Crystal structure of nafamostat dimesylate
title_full Crystal structure of nafamostat dimesylate
title_fullStr Crystal structure of nafamostat dimesylate
title_full_unstemmed Crystal structure of nafamostat dimesylate
title_short Crystal structure of nafamostat dimesylate
title_sort crystal structure of nafamostat dimesylate
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491525/
https://www.ncbi.nlm.nih.gov/pubmed/34667626
http://dx.doi.org/10.1107/S2056989021009245
work_keys_str_mv AT fujiiisao crystalstructureofnafamostatdimesylate